Proteomika
2002
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
Description
Provider of biomarkers designed for non-invasive diagnosis of complex diseases. The company's biomarkers are diagnostic assays that offers individualized optimization of treatment regimes by measuring drug response, such as drug bioavailability and immunogenicity.
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Acquirer
Primary Office
- Parque Tecnológico de Bizkaia 504
- 48160 Derio
- Spain
+34 944 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Proteomika’s full profile, request a free trial.
Proteomika Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Seed Round | 10-Apr-2004 | Completed | Startup |
Proteomika Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Bizkaia Seed Capital | Venture Capital | Minority | 000 0000 | 000000 0 |